Arkolith/Insider Trading/CHRS/Form 4

Lanfear Dennis M

President & CEO, DirectorCoherus BioSciences, Inc. (CHRS) · full profile →Form 4 · filed Nov 24, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$451K
Net Open-Market Flow
-$451K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2023Option exercise(M)41K$1.42$58K696K
Nov 22, 2023Sell(S)223K$2.02$451K732K
Nov 22, 2023Option exercise(M)259K$1.42$368K955K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 22, 2023Option exercise(M)300K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000363) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML